Archer Materials advances silicon biochip beta prototype while reaffirming graphene as next‑generation platform

The company has selected silicon for the current prototype builds, citing faster development timelines and established manufacturing pathways. While silicon is the material of choice for the current prototype, Archer affirms that graphene remains its next-generation chip platform for future performance optimization and product expansion. The core value of Archer’s technology resides in its proprietary functionalized layer chemistry and sensing architecture, applicable across both silicon and graphene chip substrates.

Archer Materials has provided an update on its biochip program following the completion of Stage 1 project with IMEC. The company is developing advanced semiconductor devices, including chips relevant to quantum computing, sensing, and medical diagnostics. The next phase will focus on beta prototype development, incorporating cartridge engineering, readout electronics integration, stability testing, and external user validation.The company has selected silicon for the current prototype builds, citing faster development timelines and established manufacturing pathways. While silicon is the material of choice for the current prototype, Archer affirms that graphene remains its next-generation chip platform for future performance optimization and product expansion. The core value of Archer’s technology resides in its proprietary functionalized layer chemistry and sensing architecture, applicable across both silicon and graphene chip substrates.

Read More Graphene-Info – Graphene industry portal